Perpetuum

Smedenstraat 20
2610 Antwerpen
BE
Perpetuum
Foundation date
18-01-2018
Sector
#Biotechnology - TherapeuticsSubsector
- #Therapeutics - Peptides
- #Therapeutics - Proteins
- #Therapeutics - Small molecules
- #Therapeutics - Vaccines
- #Pharma - Nucleic acid drugs
Therapeutic areas
- #Cardiovascular
- #Conditions originating in the perinatal period
- #Digestive system
- #Neoplasms / cancer / oncology
- #Respiratory system
- #Skin and subcutaneous tissue
PIONEERING PLANT SCIENCE.
Perpetuum is a biotech company that develops safe, sustainable plant-based therapeutics for the effective management and improvement of healthspan of people.
Our company focuses on four R&D platforms:
Plant cell extraction
Transient expression of recombinant proteins in plants
Dendritic nano adjuvants
Biopolymer scaffolds
Upcoming events
All events-
2211 '21
Translational Immunology
Event by: VIB -
2309 '21
Genome Engineering and Synthetic Biology (4th edition)
Event by: VIB -
2004 '21
NLSDays 2021
Event by: SwedenBIO
Latest news
More news-
Bone Therapeutics and Rigenerand sign partnership for cell therapy process development
Thursday January 14th 2021
Read more
-
Celyad Oncology appoints Marina Udier, Ph.D., to Board of Directors
Tuesday January 12th 2021
Read more
-
Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study
Tuesday January 12th 2021
Read more